References
1. Gilstrap L. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA . 1995;273(5):413. doi:10.1016/0002-9378(95)90209-0
2. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics . 1972;50(4):515-525.
3. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev . 2017;3:CD004454. doi:10.1002/14651858.CD004454.pub3
4. Fowden AL, Li J, Forhead AJ. Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc . 1998;57(1):113-122. doi:10.1079/PNS19980017
5. Jellyman JK, Fletcher AJW, Fowden AL, Giussani DA. Glucocorticoid Maturation of Fetal Cardiovascular Function. Trends Mol Med . 2020;26(2):170-184.
6. Teulings NEWD, Garrud TAC, Niu Y, et al. Isolating adverse effects of glucocorticoids on the embryonic cardiovascular system. FASEB J . 2020;34(7):9664-9677. doi:10.1096/fj.202000697R
7. Garrud TAC, Giussani DA. Combined Antioxidant and Glucocorticoid Therapy for Safer Treatment of Preterm Birth. Trends Endocrinol Metab . 2019;30(4):258-269.
8. Sotiriadis A, Tsiami A, Papatheodorou S, Baschat AA, Sarafidis K, Makrydimas G. Neurodevelopmental Outcome After a Single Course of Antenatal Steroids in Children Born Preterm: A Systematic Review and Meta-analysis. Obstet Gynecol . 2015;125(6):1385. doi:10.1097/AOG.0000000000000748
9. van der Merwe JL, Sacco A, Toelen J, Deprest J. Long-term neuropathological and/or neurobehavioral effects of antenatal corticosteroid therapy in animal models: a systematic review.Pediatr Res . 2019;(November 2019):1-14. doi:10.1038/s41390-019-0712-1
10. Aghajafari F, Murphy K, Matthews S, Ohlsson A, Amankwah K, Hannah M. Repeated doses of antenatal corticosteroids in animals: A systematic review. Am J Obstet Gynecol . 2002;186(4):843-849. doi:10.1067/mob.2002.121624
11. De Vries A, Holmes MC, Heijnis A, et al. Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic-pituitary-adrenal axis function. J Clin Invest . 2007;117(4):1058-1067. doi:10.1172/JCI30982
12. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement.Int J Surg . 2010;8(5):336-341. doi:10.1016/j.ijsu.2010.02.007
13. Carey TS, Boden SD. A critical guide to case series reports.Spine (Phila Pa 1976) . 2003;28(15):1631-1634. doi:10.1097/01.BRS.0000083174.84050.E5
14. Higgins J, Green S. Assessing risk of bias in included studies.Cochrane Handb Syst Rev Interv . 2008:187-241.
15. Wells G, Shea B, O’Connell D, Peterson J, Welcho V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Heal Res Inst . 2011.
16. Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evidence-Based Med . 2018;23:60-63.
17. Batton B, Zhu X, Fanaroff J, et al. Blood Pressure, Anti-Hypotensive Therapy, and Neurodevelopment in Extremely Preterm Infants. J Pediatr . 2009;154(3):351-358. doi:10.1016/j.jpeds.2008.09.017
18. Chen XK, Lougheed J, Lawson ML, et al. Effects of repeated courses of antenatal corticosteroids on somatic development in children 6 to 10 years of age. Am J Perinatol . 2008;25(1):21-28. doi:10.1055/s-2007-995222
19. Cinar Yakar Y, Duran R, Acunas B, Aladag Ciftdemir N, Vatansever U, Sut N. The effect of antenatal steroid administration time on postnatal blood pressure in very low birth weight infants. Intensive Care Med . 2013;39(S1):S39. doi:10.1007/s00134-013-2950-8
20. Dalziel SR, Liang A, Parag V, Rodgers A, Harding JE. Blood pressure at 6 years of age after prenatal exposure to betamethasone: Follow-up results of a randomized, controlled trial. Pediatrics . 2004;114(3). doi:10.1542/peds.2004-0196
21. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-Year follow-up of a randomised controlled trial. Lancet . 2005;365(9474):1856-1862. doi:10.1016/S0140-6736(05)66617-2
22. Demarini S, Dollberg S, Hoath SB, Ho M, Donovan EF. Effects of antenatal corticosteroids on blood pressure in very low birth weight infants during the first 24 hours of life. J Perinatol . 1999;19(6 PART. 1):419-425. doi:10.1038/sj.jp.7200245
23. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics . 2000;105(6). doi:10.1542/peds.105.6.e77
24. De Vries WB, Karemaker R, Mooy NF, et al. Cardiovascular follow-up at school age after perinatal glucocorticoid exposure in prematurely born children: Perinatal glucocorticoid therapy and cardiovascular follow-up. Arch Pediatr Adolesc Med . 2008;162(8):738-744. doi:10.1001/archpedi.162.8.738
25. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children.Clin Sci . 2000;98(2):137-142. doi:10.1042/cs0980137
26. Finken MJJ, Keijzer-Veen MG, Dekker FW, et al. Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation. Arch Dis Child Fetal Neonatal Ed . 2008;93(6). doi:10.1136/adc.2007.128470
27. Gwathmey TYM, Zerihun L, Simington SW, Chappell MC, Washburn LK. Antenatal Betamethasone Exposure Increases Oxidative Stress in African-American Adolescents Born Prematurely. Circulation . 2018;127:AP241.
28. Kari MA, Hallman M, Eronen M, et al. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study. Pediatrics . 1994;93(5):730-736.
29. Kelly BA, Lewandowski AJ, Worton SA, et al. Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolism. Pediatrics . 2012;129(5). doi:10.1542/peds.2011-3175
30. Moise AA, Wearden ME, Kozinetz CA, Gest AL, Welty SE, Hansen TN. Antenatal steroids are associated with less need for blood pressure support in extremely premature infants. Pediatrics . 1995;95(6):845-850.
31. Nair G V., Omar SA. Blood pressure support in extremely premature infants is affected by different courses of antenatal steroids.Acta Paediatr Int J Paediatr . 2009;98(9):1437-1443. doi:10.1111/j.1651-2227.2009.01367.x
32. Norberg H, Stålnacke J, Nordenström A, Norman M. Repeat antenatal steroid exposure and later blood pressure, arterial stiffness, and metabolic profile. J Pediatr . 2013;163(3):711-716. doi:10.1016/j.jpeds.2013.03.074
33. South AM, Nixon PA, Chappell MC, et al. Antenatal corticosteroids and the renin-angiotensin-aldosterone system in adolescents born preterm. Pediatr Res . 2017;81(1):88-93. doi:10.1038/pr.2016.179
34. Washburn L, Chappell M, Beavers D, et al. Adult Males of Very Low Birth Weight with Antenatal Corticosteroid Exposure Exhibit an Enhanced Blood Pressure Response to Acute Stress. J Fed Am Soc Exp Biol . 2017;31(S1):852.8.
35. Dimitriou G, Kavvadia V, Marcou M, Greenough A. Antenatal steroids and fluid balance in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed . 2005;90(6):509-513. doi:10.1136/adc.2005.071688
36. Costa S, Zecca E, De Luca D, De Carolis MP, Romagnoli C. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Eur J Obstet Gynecol Reprod Biol . 2007;131(2):154-157. doi:10.1016/j.ejogrb.2006.05.006
37. Eronen M, Kari A, Pesonen E, Hallman M. The Effect of Antenatal Dexamethasone Administration on the Fetal and Neonatal Ductus Arteriosus: A Randomized Double-blind Study. Am J Dis Child . 1993;147(2):187-192. doi:10.1001/archpedi.1993.02160260077026
38. Yunis KA, Bitar FF, Hayek P, Mroueh SM, Mikati M. Transient hypertrophic cardiomyopathy in the newborn following multiple doses of antenatal corticosteroids. Am J Perinatol . 1999;16(1):0017-0021. doi:10.1055/s-2007-993830
39. Schäffer L, Burkhardt T, Tomaske M, et al. Effect of antenatal betamethasone administration on neonatal cardiac autonomic balance.Pediatr Res . 2010;68(4):286-291. doi:10.1203/PDR.0b013e3181ed0cf2
40. Davis EP, Townsend EL, Gunnar MR, et al. Antenatal betamethasone treatment has a persisting influence on infant HPA axis regulation.J Perinatol . 2006;26(3):147-153. doi:10.1038/sj.jp.7211447
41. Savoy C, Mathewson KJ, Schmidt LA, et al. Exposure to antenatal corticosteroids and reduced respiratory sinus arrhythmia in adult survivors of extremely low birth weight. Int J Neurosci . 2019;129(8):776-783. doi:10.1080/00207454.2019.1567511
42. Nixon PA, Washburn LK, O’Shea TM, et al. Antenatal steroid exposure and heart rate variability in adolescents born with very low birth weight. Pediatr Res . 2017;81(1):57-62. doi:10.1038/pr.2016.173
43. McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev . 2020;2021(2). doi:10.1002/14651858.CD004454.pub4
44. Mahony R, McKeating A, Murphy T, McAuliffe F, O’Herlihy C, Foley M. Appropriate antenatal corticosteroid use in women at risk for preterm birth before 34 weeks of gestation. BJOG An Int J Obstet Gynaecol . 2010;117(8):963-967. doi:10.1111/j.1471-0528.2010.02590.x
45. Ivy JR, Carter RN, Zhao JF, et al. Glucocorticoids regulate mitochondrial fatty acid oxidation in fetal cardiomyocytes. J Physiol . 2021;599(21):4901-4924. doi:10.1113/JP281860
46. Agnew EJ, Ivy JR, Stock SJ, Chapman KE. Glucocorticoids, antenatal corticosteroid therapy and fetal heart maturation. J Mol Endocrinol . 2018;61(1):R61-R73. doi:10.1530/JME-18-0077
47. Wyrwoll CS, Noble J, Thomson A, et al. Pravastatin ameliorates placental vascular defects, fetal growth, and cardiac function in a model of glucocorticoid excess. Proc Natl Acad Sci U S A . 2016;113(22):6265-6270. doi:10.1073/pnas.1520356113
48. Rog-Zielinska EA, Richardson R V., Denvir MA, Chapman KE. Glucocorticoids and foetal heart maturation; implications for prematurity and foetal programming. J Mol Endocrinol . 2013;52(2). doi:10.1530/JME-13-0204
49. Niu Y, Herrera EA, Evans RD, Giussani DA. Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy. J Physiol . 2013;591(20):5083-5093. doi:10.1113/jphysiol.2013.258210
50. Gay MS, Li Y, Xiong F, Lin T, Zhang L. Dexamethasone treatment of newborn rats decreases cardiomyocyte endowment in the developing heart through epigenetic modifications. PLoS One . 2015;10(4):1-20. doi:10.1371/journal.pone.0125033
51. Bal MP, De Vries WB, Van Oosterhout MFM, et al. Long-term cardiovascular effects of neonatal dexamethasone treatment: Hemodynamic follow-up by left ventricular pressure-volume loops in rats. J Appl Physiol . 2008;104(2):446-450. doi:10.1152/japplphysiol.00951.2007
52. Bal MP, De Vries WB, Van Der Leij FR, et al. Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilatation in early life: Studies in 4-week-old prepubertal rats. Pediatr Res . 2005;58(1):46-52. doi:10.1203/01.PDR.0000163617.01673.9A
53. Dodic M, Samuel C, Moritz K, et al. Impaired cardiac functional reserve and left ventricular hypertrophy in adult sheep after prenatal dexamethasone exposure. Circ Res . 2001;89(7):623-629. doi:10.1161/hh1901.097086
54. Dodic M, Peers A, Coghlan J, et al. Altered cardiovascular haemodynamics and baroreceptor-heart rate reflex in adult sheep after prenatal exposure to dexamethasone. Clin Sci (Lond) . 1999;97(1):103-109.
55. Dodic M, Peers A, Coghlan J, Wintour M. Can Excess Glucocorticoid, Predispose to Cardiovascular and Metabolic Disease in Middle Age?Trends Endocrinol Metab . 1999;10(3):86-91.